InsidersTradesSigma
Follow the 3D Medicines Inc. share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €638.2m. The latest transaction was reported on 18 August 2026 (Other). Among the most active insiders: Zhu Jinqiao. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
3D Medicines Inc. is a company focused on developing innovative therapies for cancer treatment. It specializes in the research and commercialization of drugs based on advanced technologies.